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INTRODUCTION
Orthotopic liver transplantation (OLT) has become the standard of care for patients with endstage liver disease and hepatic malignancies. However, early allograft dysfunction (EAD), an important cause of morbidity and mortality for liver transplant recipients is not uncommon, with the incidence at approximately 25%, varying between centers from 10.8% to 36.3% (1) . Ischemiareperfusion injury (IRI), a leading cause of EAD, represents a major risk factor for acute and chronic rejection, and a contributing factor in severe organ shortage available for transplantation. These adverse effects become even more significant in expanded criteria liver transplants, including those from marginal, deceased and non-heart beating donors. However, despite obvious clinical importance, the mechanisms that account for liver IRI are not well appreciated and novel strategies to improve clinical outcomes and expand donor pool to alleviate organ shortage, are warranted (2) .
In the pathophysiology of liver IRI, primary hepatic insult during ex vivo cold storage triggers stressed cells to secrete danger-associated molecular patterns (DAMPs), such as histone H3 and high-mobility group box 1 (HMGB1). The latter mount a cascade of innate immune-dominated inflammatory responses during the reperfusion phase, accelerating the hepatocellular OLT damage and undermining long-term survival and clinical outcomes. Although cell death during the reperfusion phase appears to proceed primarily via oncotic necrosis (3) (4), consistent with our own and others' studies demonstrating the contribution of apoptosis and necroptosis in IRI pathology (5) (6) (7) , the hepatocellular death program at the reperfusion phase may encompass a mixture of diverse molecular mechanisms. While the restoration of hepatic blood flow is the principal cause of tissue injury, pre-transplant cold storage itself can trigger organ damage as well (8) . Apoptosis signal-regulating kinase 1 (ASK1), a member of the MAP3K family, becomes activated by a wide range of extra-and intra-cellular stressors. Activation of p38 MAPK was reported in cold-induced tissue injury (9) (10); while a recent study has identified tissue-specific contribution of ASK1 and p-p38 pathways in cell death signaling (11) . The role of ASK1/p-p38 axis in the mechanism of liver transplant damage has not been studied before.
The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1, CC1; CD66a)
is a transmembrane glycoprotein expressed on epithelial, endothelial and immune cells. Originally identified as a substrate of the insulin receptor tyrosine kinase in rat hepatocytes (12) (13) , and abundantly expressed by bile capillary side of hepatocytes in rodents and humans, CEACAM1 is involved in hepatocyte differentiation/liver regeneration, and increasingly recognized as the master regulator of insulin clearance, while preventing metabolic disorders, such as diabetes and nonalcoholic steatohepatitis (NASH) (14) (15) . The emerging evidence of hepatic CEACAM1 residing at the central hub of immune liver injury and metabolic homeostasis (16) , provide the rationale to study its relevance in IRI-OLT in the current study.
Here, we asked as to whether and how hepatic CEACAM1 may affect susceptibility of liver grafts to peri-transplant stress and thus influence clinical outcomes in mouse and human OLT recipients. Our findings document the functional role of CEACAM1 signaling to alleviate graft damage during cold preservation, mitigate post-transplant IRI and improve early clinical outcomes;
while identifying an underling ASK1-p38 molecular mechanism of cytoprotection. In the experimental arm, we employed a clinically-relevant mouse OLT model with extended ex vivo cold storage, to show that liver cell-specific CEACAM1 signaling protected OLT against cold stress, alleviated IRI, and improved overall survival. By demonstrating that adjunctive ASK1 inhibition prevented otherwise fulminant hepatocellular damage due to hepatic CC1 genetic ablation, we have identified stress-activated ASK1 as a key CEACAM1 downstream molecule in liver graft protection. In the clinical arm of sixty human liver transplant patients, cold stored human donor livers with decreased CEACAM1 levels exhibited increased ASK1 signaling and inferior post-OLT function. Notably, reduced hepatic CEACAM1 expression was identified as one of the independent predictors for EAD in human OLT recipients. Thus, as a checkpoint regulator of IR-stress and hepatic sterile inflammation, CEACAM1 may not only serve as a target for therapeutic OLT modulation, but also as a denominator of donor liver tissue quality. The latter may have a major clinical impact on OLT outcomes as currently there is no reliable way to assess donor organ quality preoperatively.
RESULTS

Hepatic CC1 null mutation exacerbates IRI in mouse OLT
We first aimed to determine the influence of graft-specific disruption of CEACAM1 signaling on the severity of hepatic IRI in a clinically-relevant mouse OLT model with extended ex vivo cold storage (4 o C/18h), which mimics marginal human liver graft scenario. At 6h after transplantation into WT recipients, CC1-deficient (CC1 -/-; KO) liver grafts (n=6) exhibited increased sinusoidal congestion, edema vacuolization and hepatocellular necrosis ( Figure 1A) ; enhanced Suzuki's histological IRI grading (WT>WT=3.5±1.0 vs. CC1-KO>WT=6.0±1.3, p=0.0005, Figure 1B) ; higher sAST/sALT levels (sAST: WT>WT=3053±501 vs. CC1-KO>WT=6097±1324 IU/L, p<0.0001; sALT: WT>WT= 6616±1065 vs. CC1-KO>WT= 9807±2655, p=0.0087; Figure 1C ); and elevated frequency of TUNEL+ necrotic/apoptotic cells (WT>WT=46.6±4.9 vs. CC1-KO>WT=83.7±14.7/HPF, p<0.0001, Figure 1D and E) as compared with CC1 proficient (WT>WT) grafts (n=6). Thus, disruption of CEACAM1 signaling in the donor liver augmented IRI and enhanced hepatocellular death in murine OLT.
Hepatic CC1 ablation enhances IR-inflammatory phenotype in mouse OLT
Since the release of DAMPs, such as HMGB1, from damaged cells triggers a cascade of inflammatory cytokine/chemokine events, which further aggravate organ damage (17) , we aimed to evaluate the impact of graft CC1 deficiency on the release of HMGB1 and accompanied innateimmune response in our model. At 6h post-reperfusion, CC1-KO liver grafts (CC1-KO>WT) showed higher serum HMGB1 levels ( Figure 1F ), increased frequency of intra-graft infiltration by CD11bpositive (macrophage)/Ly6G-positive (neutrophil) cells ( Figure 1D and G), along with elevated serum MCP1 ( Figure 1F ) and hepatic mRNA levels coding for MCP1, CXCL1, CXCL2 and CXCL10 ( Figure   1H ), as compared with controls (WT>WT). These data indicate the importance of graft CC1 signaling to suppress secretion of DAMPs, mitigate innate immune activation, and alleviate hepatocellular damage in IR-stressed OLT.
Hepatic CC1 deletion augments cell damage by enhancing reactive oxygen species (ROS) and HMGB1 translocation during liver cold storage
Although restoration of blood flow at reperfusion is the principal cause of liver IRI (17), cold storage itself can also trigger hepatocellular damage (8) . Having demonstrated the importance of graft CC1 expression on HMGB1 release in OLT ( Figure 1F ), we next asked as to whether CEACAM1 may affect graft injury and HMGB1 signaling during ex vivo cold storage (prior to revascularization). Herein, we focused on the liver effluent obtained by flushing the liver with physiological saline (2 ml) via a cuff placed at portal vein immediately after 18h of cold stimulation (Figure 2A ). Indeed, the flush from CC1deficient livers contained increased HMGB1 and Histone H3 levels as compared with CC1-proficient (WT) livers ( Figure 2B ), suggesting higher susceptibility of CC1-KO grafts to peri-transplant cold stress. Since the generation of ROS is one of the principal factors leading to cell death in cold-stored tissue (8) (18), we then evaluated 4-Hydroxynonenal (4HNE, a ROS metabolite) levels in our model.
Cold stimulation alone increased 4HNE expression, mainly in hepatic parenchymal cells, whereas
CC1 deficiency markedly enhanced 4HNE upregulation ( Figure 2C , upper panel; red stains).
Moreover, cold stress led to cytoplasmic HMGB1 translocation, while CC1 disruption further augmented extra-nuclear HMGB1 localization ( Figure 2C , middle panel). Thus, disruption of hepatic CC1 signaling increased effluence of damage-associated molecules (HMGB1/Histone H3) while enhancing 4HNE expression and extra-nuclear HMGB1 translocation during cold storage. These data suggest that graft-specific CEACAM1 was essential to inhibit local ROS generation and prevent cell damage in the early hepatic cold storage phase. Noteworthy, cold stimulation alone did not affect the frequency of TUNEL-positive cells in WT or CC1-KO liver grafts ( Figure 2C , lower panel), implying hepatic damage leading to DAMPs release ( Figure 2B ) was likely distinct from apoptotic/necrotic cell death.
Hepatic flush from CC1-KO cold-stored mouse livers enhances macrophage activation in vitro
Since the leakage of DAMPs from a cold-stored graft is not only a tissue damage indicator, but may also trigger innate inflammatory response, we next asked as to whether and how liver flush may affect bone marrow-derived macrophage (BMDM) cultures (Figure 2A and D). Indeed, liver flush from cold-stored WT livers was found to increase mRNA levels coding for MCP1, CXCL2 and CXCL10, whereas liver flush from CC1-KO livers further enhanced the pro-inflammatory gene expression program as compared to WT cultures. Thus, in the absence of hepatic CC1 signaling, cold stimulation triggered a more pronounced inflammatory response by hepatic flush in vitro, as compared to CC1proficient (WT) liver flush.
Hepatic CC1 null mutation augments cold stress-triggered upregulation of ASK1/p-p38 signaling axis
To seek a molecular signaling pathway which underlies cold-related hepatic damage, we contrasted murine WT livers at resting state (naïve), after cold storage (4 o C/18h), and after OLT reperfusion ( Figure 3A ). Cleavage of caspase 3, essential step to execute apoptosis, was pronounced at 3h post-reperfusion, while cold stress alone failed to increase cleaved caspase 3 expression.
Consistently, TUNEL-positive (apoptotic/necrotic) cells were increased in OLT ( Figure 1D ) but not during cold storage alone ( Figure 2C ). In addition, cold stimulation did not affect RIP3 (a marker of necroptosis) expression ( Figure 3B ). These findings indicate the molecular mechanism of cold stresstriggered liver graft damage was likely to be distinct from apoptosis, necrosis or necroptosis. Since recent reports have demonstrated tissue-specific importance of ASK1/p-p38 signaling in cold-stress cell damage (10) (11), we focused on ASK1/p-p38 axis in our model. Interestingly, markedly increased hepatic ASK1 and p-p38 expression seen after cold storage (4 o C/18h) in WT livers, decreased in OLT at 3h post-reperfusion ( Figure 3C ). In marked contrast, in the absence of CC1 signaling, liver grafts showed increased ASK1/p-p38 levels not only at resting state ( Figure 3D ) but also after cold storage ( Figure 3E ). Thus, CEACAM1 was essential to inhibit cold stimulation-triggered ASK1/p-p38 signaling pathway.
Hepatocyte CC1 inhibits p-p38 upregulation and cell death under cold stress via ASK1 pathway
Having demonstrated the hepatoprotective role of CEACAM1 in cold-stressed liver grafts ( Figure 2B and C) and the inhibitory function of CC1 against ASK1/p-p38 signaling ( Figure 3E ), we next asked whether ASK1/p-p38 axis may be essential for CEACAM1-mediated hepatocyte protection.
In a refined murine primary hepatocyte culture (WT), 4h of cold stimulation (4 o C) distinctly increased expression of ASK1 and p-p38 ( Figure 4A ), upregulated 4HNE expression ( Figure 4C 
ASK1 inhibition suppresses p-p38 upregulation, 4HNE overexpression, and HMGB1 translocation in cold-stressed CC1-deficient liver grafts
To verify in vivo relevance of aforementioned in vitro findings ( Figure 4 ), we next incubated CC1-KO livers with a selective ASK1 inhibitor (19) during 18h of cold storage. CC1-deficient liver grafts supplemented with ASK1 inhibitor showed suppressed p-p38 upregulation ( Figure 5A ), neither 4HNE overexpression nor cytoplasmic translocation of HMGB1 ( Figure 5B ), along with decreased HMGB1 secretion in the liver flush after cold stimulation ( Figure 5C ). Thus, liver CC1 deficiency increased p-p38/4HNE expression and promoted HMGB1 translocation/tissue damage via ASK1 signaling.
ASK1 signal inhibition during cold storage alleviates hepatic IRI and improves CC1-KO OLT survival
To investigate the function of ASK1 in aggravated hepatic IR-damage, we transplanted CC1-KO livers with or without pre-incubation with ASK1 inhibitor during cold storage into WT recipients.
Addition of ASK1 inhibitor during cold stimulation (4 o C/18h), attenuated sinusoidal congestion, edema/vacuolization and hepatocellular necrosis ( Figure 5D ), decreased sAST/ALT levels (sAST: CC1-KO>WT=6035±1688 vs. CC1-KO+ASK1 inhibitor>WT=3552±1083 IU/L, p=0.0020; sALT: CC1-KO>WT =10573±2824 vs. CC1-KO+ASK1 inhibitor>WT =6744±2648, p=0.0271; Figure 5E ), decreased Suzuki's histological grading of IRI (CC1-KO>WT =6.3±1.0 vs. CC1-KO+ASK1 inhibitor>WT =2.0±1.2, p<0.0001, Figure 5F ), suppressed frequency of TUNEL+ cell death (CC1-KO>WT=82.0±11.8 vs. CC1-KO+ASK1 inhibitor>WT=39.7±5.7 /HPF, p<0.0001, Figure 5D and G) at 6h post-reperfusion in otherwise IRI susceptible CC1-KO grafts. Moreover, unlike recipients of CC1-KO grafts with poor prognosis and outcomes as compared to WT>WT pairs (20-day survival: 0% vs 44%, p=0.0068), incubation of donor livers with ASK1 inhibitor significantly improved overall survival of CC1-KO>WT hosts (50% vs 0%, p=0.0217) ( Figure 5H ). Thus, pre-incubation of CC1-KO livers with ASK1 inhibitor during cold storage mitigated hepatic IRI and improved otherwise inferior post-OLT survival.
CEACAM1 levels in cold-stressed human donor livers negatively correlate with ASK1/p-p38 expression in OLT patients
Having demonstrated the regulatory CEACAM1 -ASK1/p-p38 crosstalk in cold-stimulated murine liver grafts, we next aimed to validate its relevance in clinical liver transplant patients. Sixty cold-stored human liver biopsies (Bx), collected at back table prior to implantation, were screened by Western blots for CEACAM1, ASK1 and p-p38 protein levels with β-actin normalization (Supplemental Figure 1A ). Hepatic CEACAM1 correlated negatively with ASK1 (r=-0.3424, p=0.0074, Supplemental Figure 1B ) and p-p38 expression (r=-0.2947, p=0.0222, Supplemental Figure 1C ). Based on Westernassisted relative CEACAM1 expression pattern, pre-transplant human Bx samples collected from sixty OLT patients were divided into low CEACAM1 (n=30) and high CEACAM1 expression groups (n=30), based on the relative CEACAM1/β-actin levels, according to median split method (cutoff=0.85, median, Figure 6A ). There was no correlation between CEACAM1 classification and recipient/ surgical parameters, including age, gender, race, BMI, disease etiology, ABO compatibility, MELD score, pre-transplant blood tests, pre-operative hospital stay, cold ischemia time (CIT), warm ischemia time (WIT), blood transfusions during surgery (Supplemental Table 1 ). There was no correlation between CEACAM1 grouping and donor variables, such as age, gender, race, BMI, pre-procurement blood tests, donation status (donation after circulatory death [DCD] or donation after brain death [DBD]). Consistent with Supplemental Figure 1B and C data, the low CEACAM liver transplant clinical cohort showed higher ASK1 (p=0.0459) and p-p38 (p=0.0153) levels as compared with high CEACAM1 cases ( Figure 6B ). Representative Western blots are shown in Figure 6C . Consistent with mouse OLT data ( Figure 2C ), low CEACAM1 levels in clinical liver Bx samples were associated with increased 4HNE ( Figure 6D ) and enhanced cytoplasmic HMGB1 translocation ( Figure 6E ).
CEACAM1 levels prior to liver implantation associate with the hepatocellular function in human OLT recipients
Since disruption of liver CEACAM1 signaling in mouse OLT not only affected stress resistance under cold storage (Figure 2 and 3) but was also critical for post-reperfusion injury and recovery ( Figure 1 ), we next aimed to evaluate correlation between pre-transplant CEACAM1 levels and post-reperfusion hepatic damage in human OLT. Pre-transplant CEACAM1 expression correlated negatively with sAST (r=-0.3302, p=0.0100, Supplemental Figure 1D ) and sALT (r=-0.3280, p=0.0105, Supplemental Figure 1E ) levels at post-operative day 1 (POD1). In addition, low CEACAM1 cases ( Figure 6A ) exhibited significantly higher sAST at POD1-5 ( Figure 7A ) and sALT at POD1-7 ( Figure   7B ). We then analyzed liver Bx samples obtained at 2h post-reperfusion (prior to the abdominal closure) from the corresponding low vs. high CEACAM1 clinical cases. The TUNEL staining from representative post-reperfusion Bx samples is shown ( Figure 7C Figure 7E ) and rejectionfree graft survival (p=0.1674, Figure 7F ) in the low CEACAM1 group failed to reach statistical significance when compared with the high CEACAM1 group.
CEACAM1 expression prior to liver implantation dictates the incidence of early allograft dysfunction (EAD) in human OLT recipients
Having failed to establish statistical correlation between the EAD rate and pre-transplant CEACAM1 when the median level (CEACAM1/β-actin=0.85) was simply employed as a cutoff ( Figure   6A and 7D), we next aimed to seek optimal cutoff to evaluate predictive ability of pre-transplant CEACAM1 for EAD. Based on a ROC curve and Youden index on the basis of best accuracy in relation to an incidence of EAD, the optimal pre-transplant CEACAM1/β-actin cut-off values were selected by maximizing sum of sensitivity and specificity (0.71, AUROC=0.604, sensitivity=0.761, specificity=0.643) ( Figure 9A , Supplemental Table 3 ). Based on the cutoff value of CEACAM1/β-actin=0.71, sixty OLT clinical cases were classified into CEACAM1/β-actin<0.71 group (n=20) and CEACAM1/β-actin>0.71 group (n=40) ( Figure 9B ). There was no correlation between CEACAM1 classification and recipient age, gender, BMI, disease etiology, ABO compatibility, MELD score, pretransplant blood tests, CIT, WIT, blood transfusion required for OLT operations; while we found statistically significant differences in recipient race and pre-operative hospital stay (Supplemental Table 4 ). There was no correlation between CEACAM1 grouping and donor variables, including age, gender, race, BMI, pre-procurement blood tests, DCD (Supplemental Table 5 ). Likewise to Figure 7A and B data, the CEACAM1/β-actin<0.71 group showed increased sAST levels at POD1/2/4/5 and higher sALT levels at POD1-7 ( Figure 9C ). Of note, the CEACAM1/β-actin<0.71 cases experienced significantly increased incidence of EAD as compared to the CEACAM1/β-actin>0.71 cases (45.0% vs 12.5%, p=0.0088, Figure 9B ). To determine whether CEACAM1/β-actin<0.71 represents an independent predictor of EAD in our liver transplant patient cohort, we conducted multivariate analysis based on a step-wise logistic regression model by screening "pre-OLT CEACAM1/β-actin<0.71" simultaneously with recipient age (≥60 years), recipient gender (male), recipient race, recipient BMI 
DISCUSSION
Although the expression of CEACAM1 cell surface glycoprotein was originally detected on rat hepatocellular membranes (12) (13), a growing body of evidence is now linking its function with metabolic disorders, such as hepatic insulin clearance and NASH [20] . By focusing on CEACAM1 regulation in T cell activation, Horst et al reported the aggravated and persistent hepatocellular damage in CC1-deficient mice subjected to Con A-induced T cell-mediated liver injury (20) . Despite being the principal CEACAM1-expressing liver cell type, whether and how hepatocyte CEACAM1 may contribute to stress resistance remains largely unknown. Our report identifies, what we believe to be novel cytoprotective functions of and mechanisms by which hepatic CEACAM1 signaling controls IR-stress in mouse and human liver transplantation.
In the experimental arm, in a clinically relevant mouse OLT model with extended (18h) cold storage, graft CC1 null mutation exacerbated hepatic sterile IR-inflammation, and deteriorated the hepatocellular function in WT recipients. This was manifested by enhanced histopathology tissue injury scores, increased release of sAST/sALT enzymes, augmented TUNEL-positive hepatocellular death rate, accompanied by enhanced HMGB1 release, along with leukocyte trafficking and proinflammatory gene expression profiles ( Figure 1 ). Of note, our in vivo and in vitro experiments document CEACAM1 alleviated liver/hepatocyte damage in the early cold preservation phase;
whereas its deficiency enhanced 4HNE expression ( Figure 2C and 4C), augmented HMGB1 cytoplasmic translocation ( Figure 2C and 4C), increased HMGB1 release into the liver flush ( Figure   2B ), and heightened hepatocyte death program ( Figure 4C ).
In the clinical arm consisting of sixty human liver transplant recipients, low CEACAM1 expression (CEACAM1/β-actin <median, n=30) in liver grafts prior to the implantation ( Figure 6A ) was associated with increased post-OLT sAST/sALT levels ( Figure 7A and B) as compared with high CEACAM1 expressing grafts (CEACAM1/β-actin >median, n=30), supporting the clinical relevance of CEACAM1-mediated hepatoprotection. Having failed to establish statistical correlation between EAD rate and pre-transplant CEACAM1 when its median level was used as a cutoff, we established the optimized cutoff (CEACAM1/β-actin=0.71, Figure 9A ). Indeed, cold-stressed human liver grafts with CEACAM1/β-actin<0.71 experienced significantly more frequent incidence of EAD than CEACAM1/β-actin>0.71 cases (45.0% vs 12.5%, p=0.0088, Figure 9B ). In addition, considering our group classification (CEACAM1/β-actin<0.71 vs CEACAM1/β-actin>0.71) may have been biased in terms of recipient preoperative variables (Supplemental Table 3 ), we conducted a multivariate analysis of the patient cohort to estimate the independent influence of graft CEACAM1 prior to implantation upon EAD rate by simultaneously screening putative prognostic factors and the biased recipient demographic variables (race and pre-operative hospital stay). Remarkably, we have identified CEACAM1/β-actin<0.71 as one of the independent predictors of EAD (odds ratio=7.209), together with cold ischemia time (≥420min; odds ratio=13.024) ( Figure 9D ). CEACAM1 signals through long cytoplasmic tail (CEACAM1-L), which provides inhibitory functions to different receptors (21) , or through short cytoplasmic tail (CEACAM1-S) of less defined function, which may regulate mucosal immunity (22) . Our ongoing studies suggest that IR-stressed hepatocytes/sinusoidal endothelial cells are enriched in CEACAM1-S isoform, while neutrophils/ BMDM express predominantly CEACAM1-L. Indeed, in the present study ( Figure 3C ), naïve and coldstimulated mouse livers preferentially expressed CEACAM1-S (lower bands), while CEACAM1-L splicing variant (upper bands) was detected after reperfusion. Thus, tissue-resident CEACAM1-S may be key to mitigate cold-induced early hepatocellular damage; whereas CEACAM1-L is confined to OLT-infiltrating recipient immune cells after revascularization. As liver-sequestered Ly6G-positive neutrophils preferentially express CEACAM1-L isoform at 6h post-reperfusion while neutrophils express robust cytoplasmic CC1 after reperfusion (Nakamura, unpublished data), putative role of CEACAM1-L in neutrophil regulation in IRI-OLT awaits future studies. ASK1, a redox-sensitive upstream activator of JNK and p38 arms of the MAPK pathway (23), may be activated by ROS, TNFα, ER-stress, UV irradiation or calcium overload, placing ASK1 as a signaling node in which different stressors converge (24) (25) (26) (27). Increasing number of studies focus on the role of ASK1 in the pathophysiology on NASH (27), whereas the efficacy and tolerability of an ASK1 inhibitor, selonsertib, has been reported in a phase 2, randomized, open label clinical trial in patients with NASH (28) . A recent in vitro study has also demonstrated the contribution of ASK1/p-p38 signaling axis in cell-type specific death under cold stress (11) . In our mouse IRI-OLT and primary hepatocyte culture systems, cold stress triggered increased ASK1/p-p38 expression; while HMGB1, an evolutionarily conserved nuclear protein loosely bound to chromatin, is involved in DNA organization and regulation of transcription. When released by damaged cells, extracellular HMGB1 serves as an indicator of cell injury as well as a danger signal stimulating downstream inflammatory reactions via its interaction with sentinel TLR4 and upregulation of NF-κB, which leads to increased production/release of cytokines (29) (30) . In the present study, cold stimulation increased liver/native hepatocyte ROS (4HNE) expression ( Figure 2C and 4C) and HMGB1 translocation ( Figure   2B , 2C and 4C). ROS production is critically involved in cytoplasmic translocation of HMGB1 in hepatocytes (31) , while conversely hepatocyte-specific HMGB1 depletion enhances ROS production in the liver (32) . This implies that sustained ROS generation and HMGB1 translocation and release may act synergistically to aggravate liver parenchymal cell loss under sustained cold stress. In our in vivo and in vitro experimental models, cold-stressed hepatocytes were TUNEL negative (nonapoptotic/necrotic, Figure 2C and unpublished data), with increased ASK1/p-p38 signaling ( Figure 3C and 4A) and enhanced HMGB1 translocation ( Figure 2C ongoing study, incubation of donor mouse livers with ferroptosis inhibitor during cold storage alleviated classic IRI phenotype in WT>WT OLT model (Nakamura, unpublished) .
In the pathophysiology of liver IRI, innate immune-driven activation in the reperfusion phase triggers hepatocellular damage, manifested by elevated sAST/sALT levels and increased frequency of TUNEL positive (necrosis/apoptosis) cells. Meanwhile, ischemia itself causes initial hepatic damage and the release of DAMPs, such as HMGB1 and histone H3, which then ignite innate immune cascade in the early reperfusion phase. Interestingly, despite cold storage-triggered tissue damage with ample HMGB1/histone H3 ( Figure 2B ), the hepatocellular injury in our study was not accompanied by increased frequency of TUNEL-positive cells ( Figure 2C ), indicating other than apoptosis/necrosis cell death mechanism at work. Our data stress the importance of CEACAM1 signaling to alleviate aforementioned graft damage during cold stress (Figure 2) , which in turn mitigated post-reperfusion inflammatory phenotype (Figure 1 ). However, as to whether and how hepatic CEACAM1 may directly influence hepatocyte apoptosis/necrosis remains to be elucidated.
On the other hand, we have reported that Kupffer cells (liver-resident macrophages) undergo IRtriggered necroptosis (36) . Although neither cold stress nor reperfusion significantly increased hepatic expression of RIP3 (a necroptosis marker) in the present study ( Figure 3B ), macrophage-specific RIP3 seems to be specifically enhanced during the reperfusion phase as compared to the cold stress phase (Nakamura, unpublished data). Hence, distinct cell death mechanisms/signaling pathways, likely dependent on cell-type (hepatocyte, macrophage, etc.), timing (ischemia or reperfusion) and/or ischemia type (warm or cold), contribute to liver IRI-OLT pathogenesis. Since macrophages do express CEACAM1 (Nakamura, unpublished data), whether and how macrophage-specific CEACAM1 can regulate necroptosis in IR-stressed livers awaits further study.
To estimate cold preservation-induced liver graft damage, we measured HMGB1 concentration in the hepatic effluent. We are aware the initial flush from cold-stored mouse livers (Figure 2B Our current translational study highlights previously unappreciated cytoprotective function of CEACAM1 expression during liver graft cold preservation phase, and identifies the hepatocyte ASK1/p-p38 signaling axis as the molecular homeostatic mechanism. This, what we believe to be novel finding, may have important practical ramifications, especially in the context of recently reported anti-fibrotic efficacy for a first-in-class ASK1 inhibitor (selonsertib) in a clinical trial in patients with NASH (28), the next global epidemic, which will require liver transplantation. Thus, our results provide the rationale for pre-conditioning of IRI-prone CEACAM1 low expressing human liver grafts with ASK1 inhibitor to improve outcomes. In addition, by identifying decreased CEACAM1 phenotype as a poor prognostic biomarker, one may envision to enhance the CEACAM signal with its exogenous homophilic ligand (CEACAM1-Fc fusion protein) (43) during normothermic perfusion aimed to "rejuvenate" sub-optimal donor livers prior to implantation.
In conclusion, as a checkpoint regulator of IR-stress and sterile inflammation, CEACAM1 may be considered as a denominator of hepatic tissue quality. If translated to clinical practice, and confirmed for other organs, our findings would have a major impact on transplant outcomes as currently there is no reliable way to assess donor organ quality preoperatively.
METHODS
Clinical liver transplant study
The study was approved by the UCLA Institutional Review Board (IRB protocol 13-000143, 18-000216). We performed a retrospective analysis of sixty adult patients (age ≥ 18 years) who underwent orthotopic liver transplantation (OLT) (May 2013 -August 2015). All the recipients received routine standard of care and immunosuppressive therapy, as specified by UCLA liver transplant protocols. Recipients who underwent re-transplant were excluded from the study. Donor livers, procured from donation after brain death or cardiac death with standardized techniques, were perfused with and stored in UW solution (Niaspan; Bristol-Meyers Squibb Pharma, Princeton, NJ). 
Mouse orthotopic liver transplantation
We used a mouse model of ex-vivo hepatic cold storage followed by orthotopic liver transplantation (OLT), as described by our group (46) . To mimic "marginal" human OLT setting, and to focus on putative hepatic CEACAM1 cytoprotective functions while avoiding confounding host alloimmune MHC responses, donor livers (WT or CC1 -/-; BL6) stored in UW solution (4 o C/18h) were transplanted to syngeneic rather than allogeneic recipient mice. In separate experiments, donor livers were incubated with ASK1-specific small molecule inhibitor (10ug/15ml, MSC2032964A, R&D Systems, Minneapolis, MN) throughout 18h of cold storage. Liver graft and serum samples were collected at 6h post-reperfusion, the peak of hepatocellular damage in this model. Separate OLT recipient groups were monitored for survival. The sham group underwent the same procedures except for OLT. To study the influence of cold ischemia alone, some livers/liver flush (after infusion of 2ml of physiological saline via a cuff in portal vein) were obtained shortly after completion of ex vivo storage.
Hepatocellular function assay
Serum AST/ALT levels were measured with Infinity™ AST/ALT Liquid Stable Reagent (Thermo Scientific, Rockford, IL) and validated with Validate ® GC3 (Maine Standards Company, LLC, ME).
OLT histology and IRI grading
Formalin-fixed paraffin-embedded liver sections (5µm) were stained with hematoxylin and eosin (H&E). The severity of IRI was graded using Suzuki's criteria (47) .
TdT-mediated dUTP nick end labeling (TUNEL) assay
Cell death in liver sections (5µm) was detected by In Situ Apoptosis Detection Kit (Clontech, San Diego, CA, USA) according to the manufacturer protocol. Results were scored semi-quantitatively by blindly counting the number of positive cells in 10 HPF/section (48) .
ELISA
Serum concentration of high-mobility group box 1 (HMGB1; MyBioSource, San Diego, CA) and MCP1 (Thermo Scientific) was measured by ELISA kit according to the manufacturer protocol (49) .
Bone marrow-derived macrophage (BMDM) cultures
Femurs and tibias were removed from WT mice, and bone marrow derived macrophages were generated, as described (50) . Cells were incubated (6h) with 100μl of liver flush obtained from WT or CC1-KO cold-stored liver grafts.
Hepatocyte isolation and cultures
Primary mouse hepatocytes, isolated by a two-stage collagenase perfusion method (51), were cultured with or without cold stress (4 o C) for indicated time periods (2h/4h/6h). In some experiments, hepatocytes were transfected with ASK1-siRNA (Santa Cruz Biochemistry, Santa Cruz, CA) using Lipofectamine reagent (Invitrogen, Waltham, MA) in advance to cold stimulation (6) . Dead cells were detected using Live/Dead Cell Staining Kit II (PromoCell GmbH, Heidelberg, Germany) according to the manufacturer protocol.
Western blot assay
Proteins were extracted from tissue/cell samples, and their concentration measured using BCA Protein Assay Kit (Thermo Scientific). Equal amount of protein was electrophoresed, blotted, incubated with primary Ab, secondary HRP-conjugated Ab, and developed. Primary Ab detecting HMGB1 (6893/D3E5), Histone H3 (4499/D1H2), cleaved caspase 3 (9664/5A1E), RIP3 (95702/D4G2A), CC1 (14771/D1P4T), ASK1 (8662/D11C9), p-p38 (4511/D3F9), Vinculin (VCL)(18799/E1E9V), β-actin (12620/D6A8, Cell Signaling Technology, Danvers, MA) were used. To compare target protein expression in multiple human OLT samples, densitometry quantification was conducted, as reported (50) . Briefly, in a preliminary study, one of the Bx samples expressing all target proteins was chosen and assigned as a "control" sample. Equal amount of protein lysate from each sample was applied to each well/gel, and the target band intensity was expressed as relative band intensity to that of the positive control in the same gel. The target relative protein value was further normalized according to β-actin intensity.
Quantitative RT-PCR analysis
RNA extracted with RNAse Mini Kit (Qiagen, Germantown, MD) was reverse-transcribed into cDNA. Quantitative PCR was performed using QuantStudio 3 (Applied Biosystems, Foster City, CA).
The primer sequences are listed in Supplemental Table 5 . The expression of the target gene was normalized to the housekeeping HPRT, β2M or GAPDH (52) .
Immunofluorescence
Mouse liver samples were stained with rabbit anti-CD11b Ab (ab133357/EPR1344, Abcam, Cambridge, MA) and rat anti-Ly6G Ab (551459/1A8, BD Biosciences, San Jose, CA). Hepatic CD11b+/Ly6G+ cells were scored semi-quantitatively by blindly counting cells in 10 HPF/section (x400). Mouse and human liver samples were stained with sheep anti-CC1 Ab (AF6480, R&D Systems, Minneapolis, MN), rabbit anti-4HNE Ab (ab46545, Abcam), and rabbit anti-HMGB1 Ab (ab79823/EPR3507, Abcam). Mouse hepatocytes were stained using rabbit anti-4HNE Ab and rabbit anti-HMGB1 Ab. Signals were visualized with secondary Alexa Fluor Abs.
Statistical analysis
For mouse experiments, comparisons between two groups or multiple groups were assessed using a Student's t-test or 1-way ANOVA followed by Tukey's HSD test, respectively. For human data, continuous values were analyzed by Mann-Whitney U test and categorical variables by Fisher's exact test. A multivariable analysis based on a stepwise logistic regression model was used to identify independent predictive factors of EAD. Cumulative survival rates were estimated using the Kaplan-Meier method, and survival curves were compared using log-rank tests. Identification of an optimal CM1/β-actin cutoff value was done via a receiver operating characteristics (ROC) analysis, and Youden's index as the basis for determining the best accuracy in relation to EAD incidence. All Pvalues were two-tailed, and P<0.05 was considered statistically significant. JMP for Windows 8.0 (SAS Institute, Cary, NC) was used for statistical analyses.
Study approval
All human studies were approved by the UCLA Institutional Research Board (IRB protocol 13-000143) and written informed consent was received from participants prior to inclusion in the study.
All mouse experiments were approved by the UCLA Animal Research Committee (ARC #1999-094). 
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Figure 7: Low CEACAM1 levels impair hepatocellular function in human OLT recipients:
Pre-transplant (post cold storage) human liver Bx samples were divided into low (n=30) and high (n=30) CEACAM1 expression groups, based on the relative CEACAM1/β-actin levels (please see Figure 6A ). Fig. 6A for details). Post-OLT Bx were obtained at 2h after reperfusion from corresponding cases, followed by qRT-PCR-assisted detection of mRNA coding for TLR4, CD80, CD86, CXCL10, CD68, Cathepsin G, CD28, CD4 and IL17. Data normalized to GAPDH gene expression are shown in dot plots and bars indicative mean ± SEM. # p<0.05 (Mann-Whitney U test). A receiver operating characteristics (ROC) analysis of CEACAM1/β-actin for predicting EAD. Based on a ROC curve and Youden index on the basis of best accuracy in relation to EAD incidence, the CEACAM1/β-actin cutoff value of 0.71 was determined. Area under the receiver operating characteristic curve, AUROC. (B) Based on the optimal cutoff value (0.71), sixty human OLTs were classified into CEACAM1/β-actin<0.71 (n=20) and CEACAM1/β-actin>0.71 cases (n=40), and the incidence of EAD was evaluated. # p<0.05 (Fisher's exact test). (C) Serum AST and ALT levels at POD1-7. Data shown as mean ± SEM. # p<0.05 (Mann-Whitney U test). (D) Stepwise multivariate logistic regression analysis was performed to identify independent risk factors of EAD. 
